Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Best Pract Res Clin Gastroenterol. 2014 Nov 12;29(1):3–16. doi: 10.1016/j.bpg.2014.11.001

Table 3.

Validated human cell lines used in Barrett’s esophagus and esophageal adenocarcinoma research

Cell Line Type Background Ref
EPC2-hTert INE Squamous esophageal epithelium from male non-BE
patient–immortalized by hTERT
(50, 51).
HET1A INE Squamous esophageal epithelium–immortalized by
SV40 virus Large T antigen
(50, 60,
61)
NES-B3T INE Squamous esophageal epithelium from BE patient–
immortalized by hTERT
(50, 51).
NES-G2T INE Squamous esophageal epithelium from non-BE
patient–immortalized by hTERT
(50, 51).
BAR-T IBE hTERT immortalized non dysplastic Barrett’s
esophagus from a 69 year-old male
(52)
CP-A IBE hTERT immortalized non dysplastic Barrett’s
esophagus
(53)
CP-B IBE hTERT immortalized dysplastic Barrett’s esophagus (53)
CP-C IBE hTERT immortalized dysplastic Barrett’s esophagus (53)
CP-D IBE hTERT immortalized dysplastic Barrett’s esophagus (53)
ESO26 EAC Established from a 51 year-old Caucasian male with a
primary tumor located at the gastroesophageal
junction and distal esophagus with known lymph node
and distant metastases.
(48, 49)
ESO51 EAC Established from a 74 year-old Caucasian male with a
primary adenocarcinoma of the distal esophagus and
Barrett’s esophagus.
(48, 49)
FLO-1 EAC Established from a primary distal esophageal
adenocarcinoma in a 68 year-old Caucasian male.
(48, 49)
JH-EsoAd1 EAC Established from a distal esophageal adenocarcinoma
(moderately to poorly differentiated) within Barrett’s
esophagus.
(48, 49)
KYAE-1 EAC Established from the pleural effusion from a from a 60
year old Asian male with a distal esophageal adenocarcinoma.
(48, 49)
OACM5.1 EAC Established from a lymph node metastasis from a 47
year-old Caucasian female with primary
adenocarcinoma of distal esophagus and Barrett’s
esophagus. The patient also exhibited pleural
metastases.
(74)
OACP4C EAC Established from a primary gastric cardia tumor in a
55 year-old Caucasian male. The patient also
exhibited lymph node and pleural metastases.
(48, 49)
OE19 EAC Also known as JROECL19, was established from a
well-differentiated adenocarcinoma of gastric
cardia/esophageal gastric junction of a 72 year old
male patient.
(75)
OE33 EAC Also known as JROECL33, was established from a
poorly differentiated adenocarcinoma of the lower
esophagus with Barrett’s metaplasia from a 73 year
old female patient.
(75)
SK-GT-4 EAC Established from a primary well-differentiated
adenocarcinoma arising in the distal esophagus within
Barrett esophagus of an 89 year-old Caucasian male.
(76)

INE: immortalized normal esophagus; IBE: immortalized Barrett’s esophagus; EAC: Esophageal adenocarcinoma; hTERT: human telomerase gene;